# What If We Could Map Inflammation Like Waze Maps Roads? | Sen-Jam Pharmaceutical

- Canonical URL: https://wefunder.com/feed/376866
- Entity ID: wefunder:feed_item:376866
- Published at: 2026-08-30 22:53:51 UTC
- Updated at: 2026-09-07 05:54:44 UTC

## Author
Jim Iversen

## Subject
Sen-Jam Pharmaceutical

## Content
Dear Sen-Jam Community,Most of us have used Waze to find a better route. It learns from every journey—mapping roads, recognizing patterns, anticipating obstacles and adapting as conditions change.At Sen-Jam, we asked a much bigger question:What if we could do something similar for inflammation and drug development?The video below introduces our Innate Inflammation Atlas and how Galaxy, Sen-Jam’s computational drug discovery and development platform, is designed to turn that map into an increasingly intelligent navigation system for therapeutic development. Galaxy brings together three connected engines: Atlas maps inflammatory biology, drug mechanisms and potential therapeutic combinations. Constellation helps identify the highest-value path for each opportunity. Sextant monitors the changing scientific, clinical, intellectual property and market landscape as we move forward. Together, the goal is not simply to identify promising drug combinations. It is to help us make better decisions about what to pursue, why to pursue it and what evidence is needed next.That system continues to get smarter. Our current work includes expanding Atlas with licensed DrugBank data, connecting Galaxy more deeply to Sen-Jam’s own assets and clinical evidence, and developing Opportunity Maps that distinguish what we know, what remains uncertain and where the highest-value next steps may lie.This is an important part of the infrastructure we believe can help Sen-Jam translate years of work decoding inflammatory biology into a more focused, efficient and valuable therapeutic pipeline.As we advance Galaxy alongside our therapeutic programs, our current bridge financing is also approaching its final stretch. The common-share bonus incentive will continue stepping down before ending September 17, with the bridge round scheduled to close October 1.Accredited investors considering participation can review the current offering terms and remaining incentive on our Wefunder page.At Sen-Jam, our ambition is larger than treating any single condition. We are working to decode the biology of resilience—and use what we learn to help people live longer, healthier and more resilient lives.Thank you for believing in the work and for your continued support,JimAll investments involve risk, including the possible loss of capital. Bonus perks, if applicable, are subject to the terms of the offering and Wefunder materials. Please review the full offering materials on Wefunder before making any investment decision.